121 related articles for article (PubMed ID: 16487326)
1. Plasmodium vivax dihydrofolate reductase as a target of sulpha drugs.
Djapa LY; Zelikson R; Delahodde A; Bolotin-Fukuhara M; Mazabraud A
FEMS Microbiol Lett; 2006 Mar; 256(1):105-11. PubMed ID: 16487326
[TBL] [Abstract][Full Text] [Related]
2. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.
Patel O; Karnik K; Macreadie IG
FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211
[TBL] [Abstract][Full Text] [Related]
3. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
Djapa LY; Basco LK; Zelikson R; Rosowsky A; Djaman JA; Yonkeu JN; Bolotin-Fukuhara M; Mazabraud A
Mol Biochem Parasitol; 2007 Nov; 156(1):89-92. PubMed ID: 17727978
[TBL] [Abstract][Full Text] [Related]
4. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
5. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent.
Kaur S; Prajapati SK; Kalyanaraman K; Mohmmed A; Joshi H; Chauhan VS
Acta Trop; 2006 Feb; 97(2):174-80. PubMed ID: 16310156
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia.
de Pécoulas PE; Tahar R; Yi P; Thai KH; Basco LK
Acta Trop; 2004 Sep; 92(1):1-6. PubMed ID: 15301969
[TBL] [Abstract][Full Text] [Related]
8. Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
[TBL] [Abstract][Full Text] [Related]
9. Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand.
Rungsihirunrat K; Sibley CH; Mungthin M; Na-Bangchang K
Am J Trop Med Hyg; 2008 Mar; 78(3):462-7. PubMed ID: 18337344
[TBL] [Abstract][Full Text] [Related]
10. Allelic polymorphism in the Plasmodium vivax dihydrofolate reductase gene among Indian field isolates.
Prajapati SK; Joshi H; Valecha N; Reetha AM; Eapen A; Kumar A; Das MK; Yadav RS; Rizvi MA; Dash AP
Clin Microbiol Infect; 2007 Mar; 13(3):331-4. PubMed ID: 17391393
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
[TBL] [Abstract][Full Text] [Related]
12. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
[TBL] [Abstract][Full Text] [Related]
13. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
[TBL] [Abstract][Full Text] [Related]
14. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Barnadas C; Musset L; Legrand E; Tichit M; Briolant S; Fusai T; Rogier C; Bouchier C; Picot S; Ménard D
Am J Trop Med Hyg; 2009 Jul; 81(1):19-22. PubMed ID: 19556560
[TBL] [Abstract][Full Text] [Related]
15. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli.
Tahar R; de Pécoulas PE; Basco LK; Chiadmi M; Mazabraud A
Mol Biochem Parasitol; 2001 Apr; 113(2):241-9. PubMed ID: 11295178
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human dihydrofolate reductase activity and expression.
Abali EE; Skacel NE; Celikkaya H; Hsieh YC
Vitam Horm; 2008; 79():267-92. PubMed ID: 18804698
[TBL] [Abstract][Full Text] [Related]
17. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
18. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
[TBL] [Abstract][Full Text] [Related]
19. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
